31 Mar 2020
Assets8.72
Total Income11.69
Profit After Tax0.02
NET Worth2.02
Total Borrowing6.33
At a glance
Updated 2026-08-23The shares listed at ₹29.00, a 3.57% move from the issue price. Mono Pharmacare is a SME IPO with an issue size of ₹14.84 crore, proposed for listing on NSE SME. The offer opens on 28th Aug 2023 and closes on 30th Aug 2023. The issue structure includes a fresh issue of ₹14.07 crore. The current listing schedule points to 7th Sep 2023.
Issue details
Listing atNSE SME
Issue typeBook Build Issue
Issue size₹14.84 Cr
Fresh issue₹14.07 Cr
Face value₹10
Price band₹26.00–₹28.00
Allotment4th Sep 2023
Listing7th Sep 2023
Listing performance
Full performance ↗Issue price₹28.00
Listing price₹29.00
Current price—
Listing gain3.57%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹2.00
GMP / upper price7.14%
Est. listing₹30.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens28th Aug 2023
Closes30th Aug 2023
Allotment4th Sep 2023
Refund5th Sep 2023
Demat6th Sep 2023
Listing7th Sep 2023
Subscription demand
Full bidding ↗Total13.42×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 4000 | ₹112,000 |
Company
Incorporated1994
Use of proceeds
| Object | Amount |
|---|---|
| To meet the working capital requirements | ₹8.98 Cr |
| General corporate purposes; and | ₹3.66 Cr |
Financials
Full financials ↗31 Mar 2021
Assets11.22
Total Income28.38
Profit After Tax0.10
NET Worth3.70
Total Borrowing6.08
31 Mar 2022
Assets14.38
Total Income37.10
Profit After Tax0.35
NET Worth4.28
Total Borrowing6.44
31 Mar 2023
Assets62.57
Reserves and Surplus1.32
Trend chart₹ crore
KPIs
| KPI |
|---|
| ROE |
| ROCE |
| Debt / Equity |
| RoNW |
| PAT Margin |
Valuation & shareholding
Pre-IPO EPS1.99
Post-IPO P/E40
Promoter holding pre81.02%
Promoter holding post56.72%
Market cap₹49.47 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Issue relating expenses such as fees to Book Running Lead manager Fixed Fee, Registrar to the Issue, Legal Advisors, Auditors, statutory advertisements and other expenses incurred / to be incurred including promotional expenses | ₹0.61 Cr |
| Underwriting commission, brokerage and selling commission (including Commission/ processing fees for SCSBs, Sponsor Bank, Members of the Syndicate, Registered Brokers, RTAs and CDPs | ₹1.49 Cr |
| Listing fees, Stock Exchange processing/ listing fees, software fees, Depositories’ fees, other regulatory expenses and sundry expenses | ₹0.10 Cr |
Registrar & lead managers
Registrar
Bigshare Services Pvt.Ltd.Lead managers
- Unistone Capital Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-23.